Tagged with M

Puerto Rico Puerto Rico’s healthcare insurance market is the first in Latin America in terms of penetration and sixth in terms of premium volume. Ángela Weyne, Insurance Commissioner of Puerto Rico, discusses how recent amendments to the Affordable Care Act (ACA) have been implemented locally, how she is spurring healthy competition among…

pharma Ana Myriam Irizarry, plant manager for LifeScan in Puerto Rico, discusses the competitive nature of the facility’s production of diabetes test strips and the immense talent that Puerto Rico has to offer in terms of manufacturing talent. What makes LifeScan’s test strips so innovative? It is the quality of our…

Puerto Rico Verónica Cruz, PhD, executive vice president and COO of Puerto Rican consultancy ReComS Group, discusses the need to bring investments in the life science industry back to Puerto Rico while focusing on the country’s manufacturing strengths as a competitive advantage. What are the main challenges which ReComS is facing? Today…

Puerto Rico PharmaBoardroom spoke to Osvaldo Caro, President, Chairman and CEO of ReComS, about the legal side of the pharmaceuticals sector in Puerto Rico. What are ReComS’ defining characteristics? ReComS is the only company in Puerto Rico that provides consulting services through a combination of attorneys and other professionals. Our staff is divided…

Puerto Rico Enrique Alejandro, Director and Team Leader (Finance) of Pfizer Puerto Rico discusses the pharma company’s manufacturing assets in the country. He stresses the importance of innovation as a key to staying competitive in today’s industry. What products are being manufactured in Pfizer’s Puerto Rico facilities? In Barceloneta, our site produces Active Product…

Generics The Moroccan pharma sector is increasingly looking not just to Europe, but also to Africa. Moroccan investment in distribution to African countries is increasing. But key opinion leaders say that challenges remain. For example, Morocco would benefit from a direct export platform. “In the past Morocco always looked towards the north…

Morocco In 2014, Doliprane, Aureomycine, and Microdiol were the top three medicines in Morocco by volume. Click here to read more articles and interviews from Morocco, and to download the latest free pharma report on the country. 

Morocco All main classes increased their market share by more than 4% in Morocco in 2013. General Antiinfectives and APP Digestive Metabolism increased by over 15%. Click here to read more articles and interviews from Morocco, and to download the latest free pharma report on the country. 

healthcare In the past, the Moroccan pharmaceutical sector primarily served local needs. Now it is ramping up its research and development capabilities, looking outwards to global markets, developing partnerships with other African countries, and beginning to think about social programs such as public access to healthcare. “[Morocco’s] success grew from a…

strategic levels Umut Gökalp, managing director of Japan’s Sysmex in Turkey – a company specialising in in-vitro diagnostics – evaluates their approach to developing business opportunities in the Turkish medical device sector. He also describes how the company’s new reagent facility in Germany will help bolster it domestically and regionally. Can you tell us…

regulation Sevi Firat, Founding Partner of Firat Izgi discusses the legal challenges facing pharmaceutical companies looking to penetrate the healthcare market in Turkey, the evolution of the legal landscape and her expectations for the industry’s future. With pricing and regulations as the major challenges facing players within the Turkish pharma and…

manufacturing Pepe Rodríguez-Pérez, president of Business Excellence Consulting, tell us how he helps companies in Spain and Latin America enter the US market through Puerto Rico. He explains why he is cautious about Puerto Rico’s manufacturing growth potential. What are the factors which have led to the decline of the industry over the…